Ebola Virus Vaccine (for GSK)

About Advaxia Biologics

Advaxia Biologics is a private, revenue-generating CDMO focused on the development and manufacturing of adenovirus-based therapeutics and vaccines. The company leverages its state-of-the-art facility near Rome and a fully integrated service portfolio to support clients from preclinical stages through clinical supply, boasting a 100% batch approval rate. While its website emphasizes a services business model, the initial company data suggests an internal focus on immunology and oncology therapeutics, indicating a potential dual strategy of service provision and proprietary pipeline development, though the latter is not detailed publicly.

Therapeutic Areas